| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
R(2-(4-Nitrophenethylamino)-1-phenylethanol,Hydrochloride
|
521284-21-9 |
(alphaR)-alpha-[[[2-(4-硝基苯基)乙基]氨基]甲基]苯甲醇盐酸盐
|
米拉贝隆中间体3;(ALPHAR)-ALPHA-[[[2-(4-硝基苯基)乙基]氨基]甲基]苯甲醇盐酸盐;米拉贝隆中间体3(带盐酸盐);R-ALPHA-[[[2-(4-硝基苯基)乙基]氨基]甲基]苯甲醇盐酸盐;米拉贝隆中间体;(R)2-[[2-(4-硝基苯基)乙基]氨基]-1-苯乙醇盐酸盐;(R)-2-(4-硝基苯乙基氨基)-1-苯基乙醇盐酸盐 (米拉贝隆中间体2);R-Α-[[[2-(4-硝基苯基)乙基]氨基]甲基]苯甲醇盐酸盐
|
C16H18N2O3 |
286.32572 | 817-563-0 |
|
{3-[2-(3-chlorophenyl) ethyl] pyridine-2-yl}(1-methyl piperidine-4-yl)(methanol Hydrochloride)
|
119770-60-4 |
(1-甲基-4-哌啶基)[3-[2-(3-氯苯基)乙基]吡啶-2-基]甲酮盐酸盐
|
氯雷他定甲甲酮;(1-甲基-4-哌啶基)[3-[2-(3-氯苯基)乙基]吡啶-2-基]甲酮盐酸盐;氯雷他定甲酮杂质;氯雷他定杂质10
|
C20H23N2OCl.HCl |
379.32336 | 601-629-9 |
|
N-Methyl Desloratadine
|
38092-89-6 |
8-氯-6,11-二氢-11-(1-甲基-4-哌啶叉)-5H-苯并[5,6]环庚烷[1,2-b]吡啶
|
8-氯-6,11-二氢-11-(1-甲基-4-哌啶叉)-5H-苯并[5,6]环庚烷[1,2-B]吡啶(环合物);氯雷他定EP杂质G;氯雷他定相关物质B;11-二氢-11-(1-甲基-4-哌啶叉)-5H-苯并[5;6]环庚烷[1;8-氯-6;甲基氯雷他定;N-甲基氯雷他定
|
C20H21CLN2 |
324.85 | 641-012-1 |
|
8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one
|
31251-41-9 |
8-氯-5,6-二氢-11H-苯并[5,6]环庚烷并[1,2-b]吡啶-11-酮
|
氯雷他定相关杂质C;氯雷他定EP杂质B;8-氯-5,6-二氢-11H-苯并[5,6]环庚烷并[1,2-b]吡啶-11-酮;8-氯-5,6]环庚[1,2-B]吡啶-11-酮;8-氯-5,2-B]吡啶-11-酮;6-二氢-11H-苯并[5,6]环庚基[1,2-B]吡啶-11-酮
|
C14H10CLNO |
243.69 | 700-257-5 |
|
3-(4-chloro-phenethyl)-pyridine-2-carbonitrile
|
31255-55-7 |
3-(4-chloro-phenethyl)-pyridine-2-carbonitrile
|
2-Cyano-3-(p-chlorophenethyl)-pyridin
|
|||
|
1-methyl-4-(piperidin-4-yl)piperazine
|
53617-36-0 |
1-甲基-4-(4-哌啶基)哌嗪
|
1-甲基-4-(4-哌啶基)哌嗪,98%;1-甲基-4-(4-哌啶基)哌嗪;1-甲基-4-(哌啶基-4-YL)哌嗪;1-甲基-4-(哌啶基)哌嗪;1-甲基-4-(4-哌啶基)哌嗪盐酸盐;1-甲基-4-(4-哌啶基)哌嗪盐酸盐的
|
C10H21N3 |
183.29384 | |
|
4-Chloro-4'-fluoro-butyrophenone
|
3874-54-2 |
4-氯-4'-氟苯丁酮
|
4-氯-4'-氟苯丁酮;γ-氯代-4-氟苯丁酮;γ-氯代丁酰氟苯;4-氯对氟苯丁酮;Γ-氯-4-氟苯丁酮;4-氯-4'-氟苯丁酮,97%;苯哌利多杂质;4-氯-4'-氟苯丁酮
|
C10H10OFCl |
200.6372 | 223-395-3 |
|
4-(2-Keto-1-benzimidozolinyl) piperidine
|
20662-53-7 |
4-（2-酮酸-1-苯并咪唑）哌啶
|
4-(2-酮酸-1-苯并咪唑)哌啶;4-(2-酮-1-苯并咪唑基)哌啶;1-(4-哌啶基)-2-苯并咪唑酮;2H-苯并咪唑-2-酮,1,3-二氢-1-(4-哌啶基)-;1-(4-呱啶基)-2-苯并咪唑酮;4-(2-酮酸-1-苯并咪唑)哌啶 10G
|
C12H15N3O |
217.27 | 243-950-3 |
|
4-Bromo-2-2-diphenylbutyric acid
|
37742-98-6 |
双苯溴丁酸
|
双苯溴丁酸;4-溴-2,2-二苯基丁酸;α-(2-溴乙基)-α-苯基苯乙酸;4-溴-2,2-双苯丁酸;(双苯溴丁酸)4-溴-2,2-二苯基丁酸
|
C16H15BrO2 |
319.2 | 253-648-3 |
|
(3,3-diphenyloxolan-2-ylidene)-dimethylazanium,bromide
|
37743-18-3 |
3,3-二苯基四氢呋喃-2-亚基二甲基溴化胺
|
3,3-二苯基四氢呋喃-2-亚基二甲基溴化胺;二羟基N,N-二甲基3,3-二苯基-2(3H)-溴化呋喃翁;二甲基(四氢-3,3-二苯基-2-呋喃叉)溴化铵;二甲基溴化铵;溴化(3,3-二苯基二氢呋喃-2-基I啶)-二甲基铵;(3,3-二苯基二氢呋喃-2-基I啶)-二甲基溴化铵;洛哌丁胺杂质
|
C18H20NO+.Br- |
346.2615 | 253-649-9 |
|
4-(4-Chlorophenyl)piperidin-4-ol
|
39512-49-7 |
4-(4-氯苯基)-4-羟基哌啶
|
4-(4-氯苯)-4-羟基哌啶;4-对氯苯-4-羟基哌啶;4-(4-氯苯基)哌啶-4-醇;4-(对-氯苯基)-4-羟基哌啶;4-(对-氯苯基)哌啶-4-醇;4-羟基-4-(4-氯苯基)哌啶;4-(4-氯苯基)-4-羟基哌啶(PTD-1)游离态,溶于氯仿等,熔点136-139;4-羟基-4-(对-氯苯基)哌啶
|
C11H14ClNO |
211.69 | 254-479-8 |
|
4-(Cyclomethyl carbonyl)-5-methyl-1, 3-dioxol-2-one (OLM 45)
|
80841-78-7 |
4-氯甲基-5-甲基-1,3-二氧杂环戊烯-2-酮
|
奥美沙坦MEDOXOMIL杂质5(4-(氯甲基)-5-甲基-1,3-二氧杂-2-酮);1,3-二氧代-2-羰基-4-氯甲基-5-甲基-环戊-4-烯;氯代物;4-氯甲基-5-甲基-2-氧代-1,3-二氧杂环戊烯;4-氯甲基-5-甲基-1,3,-二氧杂环环戊烯-2-酮;4-氯甲基-5-甲基-2-氧杂-1,3-二氧杂环戊烯;奥美沙坦酯侧链;4-甲基-5-氯甲基-1,3-二氧杂环戊烯-2-酮
|
C5H5ClO3 |
148.54 | 617-178-6 |
|
Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate
|
144689-93-0 |
4-(1-羟基-1-甲基乙基)-2-丙基-1H-咪唑-5-羧酸乙酯
|
奥美沙坦咪唑乙基酯杂质;OLMESARTAN MEDOXOMIL-18;4-(1-羟基-1-甲基乙基)-2-丙基-1H-咪唑-5-羧酸乙酯;4-(2-羟基-2-丙基)-2-丙基-1H-咪唑-5-羧酸乙酯;4-(1-羟基-1-甲基乙基)-2-丙基-1H-咪唑-5-羧酸乙酯,奥美沙坦的中间体;咪唑单酯/4-(1-羟基-1-甲基乙基)-2-丙基-1H-咪唑-5-羧酸乙酯;奥美沙坦酯杂质33;奥美沙坦的中间体
|
C12H20N2O3 |
240.3 | 1592732-453-0 |
|
Trityl Olmesartan Medoxomil
|
144690-92-6 |
三苯甲基奥美沙坦酯
|
OLMESARTAN MEDOXOMIL-4;三苯甲基奥美沙坦;三苯甲基奥美沙坦酯 (99.5%);奥美沙坦酯EP杂质 D;奥美沙坦酯N1-TRITYL杂质;N1三苯甲基奥美沙坦酯;奥美沙坦酯D;( 4-(2-羟异丙基)-2-丙基-1-((2'-(2-三苯甲基-2H-四唑-5-基)-4-甲基-1H-咪唑-5-甲酸(5-甲基-2-氧杂-1,3-二氧-4-甲基)酯
|
C48H44N6O6 |
800.91 | 604-437-3 |
|
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid ethyl ester)
|
144690-33-5 |
三苯甲基奥美沙坦乙酯
|
OLMESARTAN MEDOXOMIL-19;4-(1-羟基-1-甲基乙基)-2-丙基-1-[4-[2-(三苯甲基四氮唑-5-基)苯基]苯基]甲基咪唑-5-羧酸乙酯;奥美沙坦乙酯三苯甲基杂质;三苯甲基奥美沙坦乙酯;OMSTINT-J;奥美沙坦乙酯三苯酯杂质;奥美沙坦酯杂质28;奥美沙坦酯杂质31
|
C45H44N6O3 |
716.86926 | 604-436-8 |
|
1,1(4-Chlorobutylidene) Bis-(4-fluorobenzene)
|
3312-04-7 |
4,4,-二(4-氟苯)氯丁烷
|
4,-二(4-氟苯)氯丁烷
|
C16H15ClF2 |
280.74 | 221-998-6 |
|
1-Bis(4-fluorophenyl)methyl piperazine
|
27469-60-9 |
4,4'-二氟苯甲哌嗪
|
氟桂利嗪EP杂质A;1-双(4-氟苯基)甲基哌嗪,97%;1-(4,4′-二氟二苯甲基)哌嗪;二氟二苯甲基)哌嗪;N-(4,4'-二氟苯甲基)哌嗪;双(4-氟苯基)甲基哌嗪;4,4'-二氟苯甲哌嗪;哌嗪基双(4-氟苯)甲烷
|
C17H18N2F2 |
288.33502 | 248-476-0 |
|
4-(Cyclopropylcarbonyl)-α,α-dimethylbenzeneacetic Acid
|
162096-54-0 |
4-(环丙基羰基)-alpha,alpha-二甲基苯乙酸
|
4-(环丙基羰基)-ALPHA,ALPHA-二甲基苯乙酸
|
C14H16O3 |
232.27504 | |
|
Methyl 2-(4-(4-((4-((4-hydroxyphenyl)(phenyl)methyl)piperidin-1-yl)oxy)butyl)phenyl)-2-methylpropanoate
|
154477-55-1 |
4-(4-羟基联苯甲基)哌啶-1-氧代丁基-2,2-二甲基苯乙酸甲酯
|
非索缩合物;2-[4-[4-[4-(羟基二苯甲基)-1-哌啶基]-丁酰基]苯基]-2-甲基丙酸甲酯;2-[4-[4-[4-(羟基二苯甲基)-1-哌啶基]-1-氧代丁基]苯基]-2,2-二甲基乙酸甲酯;4-(4-羟基联苯甲基)哌啶-1-氧代丁基-2,2-二甲基苯乙酸甲酯;2-[4-[4-[4-(羟基二苯甲基)-1-哌啶基]-1-氧代丁基]苯基]-2,2-二甲基乙酸甲酯 (非索非那定盐酸盐);4-(4-羟基联苯甲基)哌啶-1-氧代丁基-2,2-二甲基苯乙酸甲酯(F10)
|
C33H39NO4 |
513.67 | 691-722-0 |
|
fexofenadine
|
83799-24-0 |
非索芬那定
|
4-[4-[4-(羟基二苯基甲基)-1-哌啶基]-1-羟基丁基]-alpha,alpha-二甲基苯乙酸;非索芬那定;非索非那定;Α,Α-二甲基-4-[1-羟基-4-[4-(羟基二苯基甲基)-1-哌啶基]丁基]苯乙酸;芬非那定
|
C32H39NO4 |
501.65636 | 801-893-7 |
药智官方微信
药智官方微博
